Vergoeding 2016-2020 voor ATC-subgroep A10BH : Dipeptidylpeptidase-4-remmers

  • Raming voor de totale Zvw-populatie
  2016 2017 2018 2019 2020
A10BH01 Sitagliptine (Januvia ®) 7.859.000 7.499.100 8.040.900 9.638.100 10.227.200
A10BH02 Vildagliptine (Galvus ®) 1.721.100 1.598.900 1.473.800 1.455.700 1.409.700
A10BH03 Saxagliptine (Onglyza ®) 580.850 484.410 416.150 390.760 345.380
A10BH05 Linagliptine (Trajenta ®) 2.308.800 2.364.300 2.478.900 2.904.000 3.244.800
Totaal 12.469.750 11.946.710 12.409.750 14.388.560 15.227.080